Results
9
Stocks with a market cap under US$50M.
9 companies
Magle Chemoswed Holding
Market Cap: SEK 447.2m
Engages in research and development of pharmaceutical and medical device products in Sweden.
MAGLE
SEK 21.80
7D
15.3%
1Y
-41.7%
Moberg Pharma
Market Cap: SEK 380.9m
A pharmaceutical company, develops and commercializes medical products primarily in Sweden.
MOB
SEK 8.11
7D
-3.5%
1Y
-75.3%
Biovica International
Market Cap: SEK 144.8m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.
BIOVIC B
SEK 0.64
7D
-3.0%
1Y
-76.6%
Biosergen
Market Cap: SEK 112.5m
A biotech company, develops antifungal products.
BIOSGN
SEK 0.48
7D
-4.6%
1Y
-7.5%
Modus Therapeutics Holding
Market Cap: SEK 78.3m
A biotechnology company, develops a treatment for sepsis and septic shock in Sweden.
MODTX
SEK 2.18
7D
2.8%
1Y
50.9%
Sprint Bioscience
Market Cap: SEK 62.5m
A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.
SPRINT
SEK 0.59
7D
-0.7%
1Y
-57.0%
Lärkberget
Market Cap: SEK 47.1m
Operates as an investment company.
LARK
SEK 2.38
7D
-2.5%
1Y
-14.4%
Chosa Oncology
Market Cap: SEK 34.4m
Develops oncology drugs for the treatment of cancer.
CHOSA
SEK 0.53
7D
0%
1Y
-59.2%
Double Bond Pharmaceutical International
Market Cap: SEK 12.9m
A pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases.
DBP B
SEK 0.12
7D
9.1%
1Y
-72.7%